Back to search results

INSPIRE: Nonpharmacologic Strategies for Chronic Pain

This study, called INSPIRE, is developing and testing a mobile app and coaching program to help people manage chronic pain without medication. The program uses a blend of cognitive behavioral therapy (CBT), mindfulness, and movement, delivered through an app and supported by a weekly coach. You might be able to join if you are 18 or older, speak English, Spanish, or Cantonese, have a UCSF Health or SFHN medical provider, are willing to use a smartphone, and have chronic pain (not from cancer) for at least three months. The main goal is to see if the program can reduce your pain intensity and how much pain interferes with your daily life, measured over 12 months. The study is currently in an early development and pilot testing phase, with a larger study planned for early 2025.

Study design
This study is interventional and plans to enroll 586 participants. It will involve a mobile app and telehealth coaching program.
What's involved
You would use a mobile app and receive support from a weekly telehealth pain management coach. Your pain levels will be measured at the start, then at 3, 6, and 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06183281

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

Recruiting
NAAges 18+InterventionalTreatment
University of California, San Francisco
~586 participants
Updated 2026-07-27 on ClinicalTrials.gov
What's tested:CBT, Mindfulness, and Movement

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change from Baseline in Pain Intensity and Interference on the 11-point Pain, Enjoyment of Life, and General Activity Scale (PEG)
Measured over Baseline, 3mo, 6mo, 12mo

Conditions

Chronic Pain

Explore related trials

Chronic Pain

Where it's being run

2 sites across 1 states
California2

Study leadership

  • Jason Satterfield, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

Jason Satterfield, PhD
[email protected]
415-353-2104
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Severe mental illness or other condition preventing informed consent

What this trial measures

  • Change from Baseline in Pain Intensity and Interference on the 11-point Pain, Enjoyment of Life, and General Activity Scale (PEG)Baseline, 3mo, 6mo, 12mo

    The PEG Pain Screening Tool is a validated, self-reported 3-question survey assessing pain severity, the extent to which pain interferes with enjoyment of life, and the extent to which pain interferes with general activity. Possible scores for each question range from 0 (no pain, no interference) to 10 (worst possible pain, worst possible interference). The average of scores from the three questions yields the PEG score. Change = (PEG score at time point - PEG score at baseline)